Evidence map›Paper›PMID 30154417›Full record

ArticleCell death & disease2018

JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism.

Qin Wei, Baoyong Zhou, Gangyi Yang, Wenjing Hu, Lili Zhang, Rui Liu, Minyan Li, Kuan Wang, Harvest F Gu, Youfei Guan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Qin WeiKey Laboratory of Diagnostic Medicine (Ministry of Education) and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, P. R. China.
Baoyong ZhouDepartment of Hepatobiliary Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Gangyi YangDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.ORCID 0000-0002-6458-6747
Wenjing HuDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Lili ZhangDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Rui LiuDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Minyan LiKey Laboratory of Diagnostic Medicine (Ministry of Education) and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, P. R. China.
Kuan WangKey Laboratory of Diagnostic Medicine (Ministry of Education) and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, P. R. China.
Harvest F GuSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.ORCID 0000-0003-0583-0102
Youfei GuanAdvanced Institute for Medical Sciences, Dalian Medical University, Liaoning, P. R. China.
Zhiming ZhuDepartment of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University, Chongqing Institute of Hypertension, Chongqing, P. R. China.
Hongting ZhengDepartment of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing, P. R. China.ORCID 0000-0002-6930-0103
Jun PengAdvanced Institute for Medical Sciences, Dalian Medical University, Liaoning, P. R. China.
Ling LiKey Laboratory of Diagnostic Medicine (Ministry of Education) and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, P. R. China. liling31@hotmail.com.ORCID 0000-0002-0087-3034
Dalian Medical University · CNChongqing Medical University · CNArmy Medical University · CNKarolinska University Hospital · SEMinistry of Education · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

JAZF zinc finger 1 (JAZF1) is involved in glucose and lipid metabolisms. However, its role in aging- and nutrient-related hepatic steatosis is unclear. In the current study, we demonstrated that JAZF1 expression was markedly down-regulated in obesity-associated mice and nonalcoholic fatty liver disease (NAFLD) patients. During aging, JAZF1 expression was gradually down-regulated in both C57BL/6 J and JAZF1-Tg mice. In JAZF1-Tg mice, body fat content and hepatosteatosis were protected from HFD-induced steatosis, and accompanied by decreased lipogenesis gene expression. The inhibitory effects of hepatic steatosis in JAZF1-Tg mice, however, were disappeared during aging. In hepatocytes, over-expression of JAZF1 attenuated, while knockdown of JAZF1 enhanced the expression of lipogenesis genes. The over-expressing of JAZF1 in hepatocytes displayed the increased adenosine monophosphate-activated protein kinase (AMPK) phosphorylation and decreased sterol regulatory element-binding protein 1c (SREBP-1c) expression. The roles of JAZF1 were partially attenuated by Compound C. Mechanistically, JAZF1 suppressed SREBP-1c expression through the inhibition of transcriptional activity of liver X receptor response elements (LXREs) in the SREBP-1c promoter. Data illustrate that JAZF1 may have a crucial role in the regulation of age and nutrient-associated hepatosteatosis through an AMPK/SREBP-1c-dependent mechanism.

Indexed as

AMP-Activated Protein KinasesAnimalsCo-Repressor ProteinsDiet, High-FatDNA-Binding ProteinsFatty LiverHepatocytesHumansLipogenesisLiverLiver X ReceptorsMiceMice, Inbred C57BLNeoplasm ProteinsPromoter Regions, GeneticSterol Regulatory Element Binding Protein 1AMP-Activated Protein KinasesCo-Repressor ProteinsDNA-Binding ProteinsJAZF1 protein, humanLiver X ReceptorsNeoplasm ProteinsSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1

Identifiers

PMID30154417
PMCPMC6113258
OpenAlexW2889508718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.